MOD GRF (1-29) (CJC NON DAC) 2 mg x 1 Vial – Superior Peptide

Description

Superior Peptide MOD GRF (1-29) (CJC NON DAC) is a peptide formulation containing Modified GRF (1-29), also known as CJC-1295 without DAC, a short-acting growth hormone-releasing hormone (GHRH) analogue widely studied for its ability to stimulate endogenous growth hormone release. It is commonly researched for its role in growth hormone regulation, recovery, body composition, and metabolic function.

Each pack contains 1 vial, with 2 mg of Modified GRF (1-29) per vial. Superior Peptide MOD GRF (1-29) is supplied in a lyophilized format and is intended for research applications involving peptide science, endocrinology, and growth hormone studies.

Key Features

• Modified GRF (1-29) (CJC-1295 without DAC) peptide formulation
• 2 mg per vial
• 1 vial per pack
• Lyophilized peptide format
• Short-acting GHRH analogue
• Studied for growth hormone-releasing hormone pathways
• Research-focused peptide compound

Contents

• Active Ingredient: Modified GRF (1-29) (CJC-1295 without DAC) – 2 mg
• Quantity: 1 Vial